Scientists aim to tune cochlear implants without patient feedback
NCT ID NCT02748915
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 49 adult cochlear implant users to see if electrical measurements from the inner ear can predict the best sound levels for each person. Researchers collected data during surgery and after months of implant use, then compared it to standard hearing tests. The goal is to create a model that could help doctors set up implants more accurately, especially for people who have trouble reporting what they hear.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could lead to better, faster cochlear implant tuning, especially for patients who cannot easily describe what they hear.
- What could go wrong
- This is an observational study, not a treatment trial. The models developed may not work for all patients or implant types, and further testing is needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COCHLEAR IMPLANTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Edouard Herriot - Service ORL Pavillon U
Lyon, 69437, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the hidden toll of hearing loss?
- A digital helping hand for new hearing aid wearers?
- Could a hearing aid be a shield against dementia?
- Can an online program replace clinic visits for hearing aid users?
- Could a new test help hearing aid users hear better in crowds?
- A free app might sharpen hearing after cochlear implants — trial puts it to the test